target and correct a wide variety of mutations, allowing the development of therapeutic programs across multiple organ systems. Prime Medicine's pipeline includes investigational therapies for diseases affecting the liver, eye, blood, and central nervous system. The company integrates its proprietary delivery platforms and screening tools to enhance the specificity and durability of gene edits. Its research and development efforts aim to translate advances in genome editing into clinical applications with the potential for one-time, curative treatments.